Singh, Rishi P.

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 2,934

Current Challenges and Barriers to Real-World Artificial Intelligence Adoption for the Healthcare System, Provider, and the Patient

Singh, R. P., Hom, G. L., Abramoff, M. D., Campbell, J. P., Chiang, M. F., & on behalf of the AAO Task Force on Artificial Intelligence (2020) · Translational Vision Science & Technology

Artificial Intelligence in Healthcare and EducationRetinal Imaging and Analysis

Cited by 259

Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset

Monés, J., Singh, R. P., Bandello, F., Souied, E., Liu, X., & Gale, R. (2020) · Ophthalmologica

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 110

The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy

Abbass, N. J., Nahlawi, R., Shaia, J. K., Allan, K. C., Kaelber, D. C., Talcott, K. E., & Singh, R. P. (2025) · American Journal of Ophthalmology

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 78

Glucagon-like Peptide-1 receptor agonist impact on chronic ocular disease including age-related macular degeneration

Allan, K. C., Joo, J. H., Kim, S., Shaia, J., Kaelber, D. C., Singh, R., Talcott, K. E., & Rachitskaya, A. V. (2025) · Ophthalmology

Retinal Diseases and TreatmentsGlaucoma and retinal disorders

Cited by 54

The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Retinopathy at a Tertiary Care Center

Joo, J. H., Sharma, N., Shaia, J., Wu, A. K., Skugor, M., Singh, R. P., & Rachitskaya, A. V. (2024) · Ophthalmology Science

Diabetes Treatment and ManagementRetinal Diseases and Treatments

Cited by 37

Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis

Parpia, S., Morris, T. P., Phillips, M. R., Wykoff, C. C., Steel, D. H., Thabane, L., Bhandari, M., Chaudhary, V., for the Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group, Sivaprasad, S., et al. (2022) · Eye

Statistical Methods in Clinical TrialsStatistical Methods and Bayesian Inference

Cited by 32